Rethinking Nicotine.
- doctriss
- Jul 19
- 3 min read
Updated: 6 days ago
For private educational use only
shared for the members & guests of: The Private Members Association
Disclaimer: This article has not been approved by Dr. Bryan Ardis. It reflects our private interpretation of the insights he has shared, combined with additional research and reflections. It is offered for educational and discussion purposes only.
Dr. Bryan Ardis has been raising important questions about how nicotine may function as a protective agent in the body—especially in response to certain toxins and engineered exposures. His message challenges the public narrative and invites us to take a second look.
In simple terms, he proposes this: Nicotine, when used in clean forms such as patches, lozenges, or gum, may block harmful interactions at the cellular level by occupying receptor sites (ACE2 and nicotinic acetylcholine receptors). This may reduce the body’s vulnerability to certain venom-like peptides and other synthetic agents.
In his interviews, Dr. Ardis refers to multiple peer-reviewed studies—not just speculation. These studies explore:
How nicotine binds to nicotinic acetylcholine receptors (nAChRs)
Its potential role in blocking venom peptide activity
Its effects on reducing neurological inflammation and cytokine response
Peer-Reviewed Science to Explore
Below are several reputable sources that outline nicotine’s possible therapeutic applications. These are not endorsements—only shared for educational purposes within the private domain.
“A Nicotinic Hypothesis for COVID-19”
Changeux, Jean-Pierre et al.
This article proposes that disrupted nicotinic receptor activity may be part of COVID-19 pathology, and nicotine could play a protective role.
“Nicotine and the Nicotinic Cholinergic System in COVID-19”
Farsalinos, K. et al.
Details how nicotine could influence immune modulation and reduce severity of certain symptoms.
Search: “Nicotine neuroprotection venom nicotinic receptor”
Various studies have explored how nicotine may counteract certain neurotoxins, including snake venom peptides.
Peer-Reviewed Compilation on Therapeutic Nicotine Use
Nicotine has been studied as a potential therapy in:
Parkinson’s disease
Alzheimer’s
Ulcerative colitis
Schizophrenia
Attention disorders
plus more…
Understanding the Confusion
Much of the our fear of nicotine comes from this false equation:
Nicotine = Smoking = Cancer
But that’s not accurate. Here’s what the evidence shows:
Cigarette smoke contains thousands of toxic additives, including heavy metals, tar, and combustion byproducts.
Nicotine itself is not carcinogenic when isolated and delivered cleanly.
It occurs naturally in small amounts in foods like tomatoes, potatoes, and peppers.
While mildly habit-forming on its own, nicotine becomes far more addictive when combined with MAO inhibitors found in cigarette smoke.
How Some Are Using Nicotine as a Wellness Tool
Again, this is not a recommendation. But in private circles, individuals are exploring the low-dose, non-combustible forms such as:
Transdermal patches (3 mg)
Reported private uses include:
Enhancing mental clarity or focus
Supporting protection against certain peptides or spike-related symptoms
Managing neurological inflammation and long-haul fatigue
Increased white blood cell motility has been noticed in members when using transdermal patches (no known study, observed within our private community)
A Note of Caution and Respect
This isn’t suitable for everyone. If you are pregnant, have cardiovascular sensitivity, or have a low threshold for stimulants, use discernment. As with any natural compound, the context, awrging size, and form all matter. In the right conditions and for the right terrain, nicotine may serve as a functional tool—not a crutch, not a habit.
Resources to Share or Explore Further
Dr. Ardis Interview Library
Visit: https://www.brighteon.com/channels/drardis
Search keyword: nicotine
Qeios Article – Nicotine Hypothesis
Quick overview for laypersons and practitioners alike:
https://www.qeios.com/read/article/592
PubMed Search – Nicotine Protection Studies
To browse more clinical literature:
https://pubmed.ncbi.nlm.nih.gov/?term=nicotine+covid+protection
for more information: text PATCHES to 403.461.2423
Comments